What’s in a biotech name? How drug startups choose their brand
Elie Dolgin • March 9, 2016
The intellectual property is secure. The science is sound. You’re about to make your pitch for funding. The scary next step for a biotech entrepreneur? Picking a company name.
Continue reading at STAT.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.